Appointment of Joint Broker

RNS Number : 0581S

Accrol Group Holdings PLC

07 March 2023

 

7 March 2023

Accrol Group Holdings plc

("Accrol", the "Group" or the "Company")

APPOINTMENT OF JOINT BROKER

Accrol Group, the UK's leading independent tissue converter, is pleased to announce the appointment of Shore Capital Stockbrokers as Joint Broker, to work alongside Zeus, the Company's Nominated Adviser and Joint Broker, with immediate effect.

For further information, please contact:
Accrol Group Holdings plc
Dan Wright, Executive Chairman	Via Belvedere Communications
Gareth Jenkins, Chief Executive Officer Richard Newman, Chief Financial Officer
Zeus (Nominated Adviser & Joint Broker)
Dan Bate / Jordan Warburton	Tel: [phone]
Dominic King	Tel: [phone]
Shore Capital Stockbrokers (Joint Broker)	Tel: [phone]
Malachy McEntyre / Mark Percy / James Thomas
Belvedere Communications Limited
Cat Valentine	Tel: [phone]
Keeley Clarke	Tel: [phone]
	[e-mail]

Overview of Accrol

Accrol Group Holdings plc is a leading tissue converter and supplier of toilet tissues, kitchen rolls, facial tissues, and wet wipes to many of the UK's leading discounters and grocery retailers across the UK. The Group now operates from six manufacturing sites, including four in Lancashire, which together supply c.21.5% (volume) of the UK tissue market valued at c£2.5bn at retail sales value.

For more information, please visit www.accrol.com .

 

END

 

 

APPDQLFBXXLBBBX